Astellas Pharma Inc. (TYO:4503)
1,580.50
+24.00 (1.54%)
Aug 5, 2025, 3:30 PM JST
ShockWave Medical Market Cap
Astellas Pharma has a market cap or net worth of 2.79 trillion as of August 4, 2025. Its market cap has decreased by -4.63% in one year.
Market Cap
2.79T
Enterprise Value
3.46T
Revenue
1.94T
Ranking
n/a
PE Ratio
34.29
Stock Price
$1,580.50
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 2.79T, an increase of 215.64%. That is a compound annual growth rate of 3.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 4, 2025 | 2,786.62B | 1.45% |
Dec 30, 2024 | 2,746.92B | -9.13% |
Dec 29, 2023 | 3,022.77B | -17.34% |
Dec 30, 2022 | 3,657.07B | 5.52% |
Dec 30, 2021 | 3,465.82B | 17.06% |
Dec 30, 2020 | 2,960.81B | -15.46% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 12.08T |
Daiichi Sankyo Company | 6,807.76B |
Takeda Pharmaceutical Company | 6,586.93B |
HOYA Corporation | 5,998.27B |
Otsuka Holdings | 3,938.80B |
Terumo | 3,781.04B |
Shionogi & | 2,166.95B |
Olympus | 2,053.84B |